AmSurg Corp AMSG
67.75 0.00 (+0.00%)
At closeJun 28, 2019, 6:07 PM EDT
67.12 Day range 70.09
57.32 52-week range 84.71
- Volume
- 22.17M
- Avg volume
- 1.04M
- Open
- 68.12
- Previous close
- 67.75
- Day's range
- 67.12 – 70.09
- 52-week range
- 57.32 – 84.71
- Earnings date
- Nov 1, 2016
No chart data for this range yet.
Next earnings
Nov 1, 2016
Expected Nov 1, 2016. Consensus EPS estimate 1.04.
Financials — quick view
AMSG Revenue — quarterly 822.22M
AMSG Net income — quarterly 39.95M
AMSG EPS — quarterly 0.70
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 1, 2016 | Sep 1, 2016 | 1.04 | — | — | — |
| Aug 2, 2016 | Jun 1, 2016 | 1.02 | — | — | — |
| May 3, 2016 | Mar 1, 2016 | 0.74 | — | — | — |
| Feb 24, 2016 | Dec 1, 2015 | 1.00 | — | — | — |
| Nov 3, 2015 | Sep 1, 2015 | 0.91 | — | — | — |
| Aug 4, 2015 | Jun 1, 2015 | 0.80 | — | — | — |
News
AMSURG Reports Third-Quarter Diluted EPS of $0.69 and Adjusted
Diluted EPS of $1.13 
UBS Sees $43-$44 Deal Value For Potential TeamHealth Sale 
Benzinga's M&A Chatter for Tuesday October 4, 2016 
AMSURG Announces Second-Quarter Financial Results 
TeamHealth Management Unfazed By Envision-AmSurg Deal 
Benzinga's M&A Chatter for Wednesday June 8, 2016 
AmSurg Announces 27% Growth in First-Quarter Net Revenues, with
Strong Same-Center and Same-Contract Revenue Growth 
JP Morgan Downgrades Team Health To Neutral Amid Recent Upside 
AmSurg Reports 21% Growth in Fourth-Quarter Net Revenues, 39% Growth
in Adjusted Diluted EPS of $1.07 and Diluted EPS of $1.26 
AmSurg Reports Third-Quarter Adjusted Diluted EPS of $1.03 and
Diluted EPS of $0.83
Your note
Sign in to keep a note on AMSG — it syncs with the Stock Master app.